New high-throughput screening assay to reveal similarities and differences in inhibitory sensitivities of multidrug ATP-binding cassette transporters

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1516-1527

  Kolaczkowski, Marcin ^a   Kolaczkowska, Anna ^b   Motohashi, Noboru ^c   Michalak, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; CDR1P PROTEIN; FLUPHENAZINE; KETOCONAZOLE; M 961; PDR5P PROTEIN; PHENOTHIAZINE; RHODAMINE 6G; SNQ2P PROTEIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE; DRUG DETOXIFICATION; DRUG IDENTIFICATION; DRUG POTENTIATION; DRUG SCREENING; FLUORESCENCE ANALYSIS; FUNGAL STRAIN; FUNGUS ISOLATION; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; FLUPHENAZINE; FUNGAL PROTEINS; KETOCONAZOLE; MEMBRANE TRANSPORT PROTEINS; RHODAMINES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 65649120780     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00956-08     Document Type: Article

References (62)

1. Balzi, E., M. Wang, S. Leterme, L. Van Dyck, and A. Goffeau. 1994. PDR5. a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDRl. J. Biol. Chem. 269:2206-2214. (Pubitemid 24035434)
2. Boeke, J. D., F. LaCroute, and G. R. Fink. 1984. A positive selection for mutants lacking orotidine-5 '-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. MoI. Gen. Genet. 197:345-346.
3. Bosch, L, C. L. Crankshaw, D. Piwnica-Worms, and J. M. Croop. 1997. Characterization of functional assays of multidrug resistance P-glycoprotein transport activity. Leukemia 11:1131-1137. (Pubitemid 27345967)
4. Breeuwer, P., J. L. Drocourt, N. Bunschoten, M. H. Zwietering, F. M. Rom-bouts, and T. Abee. 1995. Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular ester-ases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product. Appl. Environ. Microbiol. 61:1614-1619.
5. Conseil, G., A. Decottignies, J. M. Jault, G. Comte, D. Barron, A. Goffeau, and A. Di Pietro. 2000. Frenyl-flavonoids as potent inhibitors of the Fdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry 39: 6910-6917. (Pubitemid 30390384)
6. Decottignies, A., L. Lambert, P. Catty, H. Degand, E. A. Epping, W. S. Move-Rowley, E. Balzi, and A. Goffeau. 1995. Identification and character-ization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J. Biol. Chem. 270:18150-18157.
7. Decottignies, A., M. Kolaczkowski, E. Balzi, and A. Goffeau. 1994. Solubili-zation and characterization of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast. J. Biol. Chem. 269:12797-12803. (Pubitemid 24202075)
8. Delaveau, T., A. Delahodde, E. Carvajal, J. Subik, and C. Jacq. 1994. PDR3, a new yeast regulatory gene, is homologous to PDRl and controls the multidrug resistance phenomenon. MoI. Gen. Genet. 244:501-511. (Pubitemid 24281464)
9. Dey, S., P. Hafkemeyer, I. Pastan, and M. M. Gottesman. 1999. A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol. Biochemistry 38:6630-6639. (Pubitemid 129514962)
10. Dufour, J. P., A. Amory, and A. Goffeau. 1988. Plasma membrane ATPase from the yeast Schizosaccharomycespombe. Methods Enzymol. 157:513-528.
11. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams and Wilkins Co., Baltimore, MD.
12. Figler, R. A., H. Omote, R. K. Nakamoto, and M. K. Al-Shawi. 2000. Use of chemical chaperones in the yeast Saccharomyces cerevisiae to enhance heterologous membrane protein expression: high-yield expression and puri-fication of human P-glycoprotein. Arch. Biochem. Biophys. 376:34-46. (Pubitemid 30205112)
13. Ford, J. M., and W. N. Hait. 1990. Pharmacology of drugs that alter multi-drug resistance in cancer. Pharmacol. Rev. 42:155-190. (Pubitemid 20291782)
14. Gerberick, G. F., and P. A. Castric. 1980. In vitro susceptibility of Pseudo-monas aeruginosa to carbenicillin, glycine, and ethylenediaminetetraacetic acid combinations. Antimicrob. Agents Chemother. 17:732-735. (Pubitemid 10155433)
15. Gietz, R. D., R. H. Schiestl, A. R. Willems, and R. A. Woods. 1995. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG pro-cedure. Yeast 11:355-360.
16. Goldstein, A. L., X. Pan, and J. H. McCusker. 1999. Heterologous URA3MX cassettes for gene replacement in Saccharomyces cerevisiae. Yeast 15:507-511. (Pubitemid 29184859)
17. Guarente, L. 1983. Yeast promoter and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol. 101:181-191.
18. Hendrich, A. B., O. Wesotowska, A. Pota, N. Motohashi, J. Moinar, and K. Michalak. 2003. Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity. MoI. Membr. Biol. 20:53-60. (Pubitemid 36460646)
19. Homolya, L., Z. Hollo, U. A. Germann, I. Pastan, M. M. Gottesman, and B. Sarkadi. 1993. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268:21493-21496. (Pubitemid 23320634)
20. Kaatz, G. W., V. V. Moudgal, S. M. Seo, and J. E. Kristiansen. 2003. Fhenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:719-726. (Pubitemid 36158106)
21. Katzmann, D. J., E. A. Epping, and W. S. Moye-Rowley. 1999. Mutational disruption of plasma membrane trafficking of Saccharomyces cerevisiae Yorlp, a homologue of mammalian multidrug resistance protein. MbI. Cell. Biol. 19:2998-3009. (Pubitemid 29144545)
22. Katzmann, D. J., P. E. Burnett, J. Golin, Y. Mahé, and W. S. Moye-Rowley. 1994. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. MoI. Cell. Biol. 14:4653-4661
23. Kessel, D., W. T. Beck, D. Kukuruga, and V. Schulz. 1991. Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51:4665-4670.
24. Kolaczkowska, A., M. Kolaczkowski, A. Goffeau, and W. S. Moye-Rowley. 2008. Compensatory activation of the multidrug transporters Pdr5p. Snq2p, and Yorlp by Fdrlp in Saccharomyces cerevisiae. FEBS Lett. 582:977-983.
25. Kolaczkowski, M., A. Kolaczowska, J. Luczynski, S. Witek, and A. Goffeau. 1998. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resis-tance network. Microb. Drug Resist. 4:143-158. (Pubitemid 28500712)
26. Kolaczkowski, M., K. Michalak, and N. Motohashi. 2003. Fhenothiazines as potent modulators of yeast multidrug resistance. Int. J. Antimicrob. Agents 22:279-283. (Pubitemid 37103214)
27. Kolaczkowski, M., M. van der Rest, A. Cybularz-Kolaczkowska, J. P. Sou-million, W. N. Konings, and A. Goffeau. 1996. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271:31543-31548. (Pubitemid 26408613)
28. Laemmli, TJ. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Leppert, G., R. McDevitt, S. C. Falco, T. K. Van Dyk, M. B. Ficke, and J. Golin. 1990. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 125:13-20. (Pubitemid 20136290)
30. Liu, R., A. Siemiarczuk, and F. J. Sharom. 2000. Intrinsic fluorescence of the F-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides. Biochemistry 39:14927-14938.
31. Longtine, M. S., A. McKenzie III, D. J. Demarini, N. G. Shah, A. Wach, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional modules for versatile and economical FCR-based gene deletion and modification in Sac-charomyces cerevisiae. Yeast 14:953-961. (Pubitemid 28328001)
32. Mahé, Y., Y. Lemoine, and K. Kuchler. 1996. The ATF binding cassette transporters Fdr5 and Snq2 of Saccharomyces cerevisiae can mediate trans-port of steroids in vivo. J. Biol. Chem. 271:25167-25172. (Pubitemid 26337877)
33. Marchetti, O., P. Moreillon, M. P. Glauser, J. Bille, and D. Sanglard. 2000. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob. Agents Chemother. 44:2373-2381. (Pubitemid 30650882)
34. Markham, P. N., E. Westhaus, K. Klyachko, M. E. Johnson, and A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408. (Pubitemid 29471218)
35. Motohashi, N., M. Kawase, J. Moinar, L. Ferenczy, O. Wesolowska, A. B. Hendrich, M. Bobrowska-Hägerstrand, H. Hägerstrand, and K. Michalak. 2003. Antimicrobial activity of /V-acylphenothiazines and their influence on lipid model membranes and erythrocyte membranes. Arzneimittelforschung 53:590-599.
36. Munder, T., and A. Hinnen. 1999. Yeast cells as tools for target oriented screening. Appl. Microbiol. Biotechnol. 52:311-320. (Pubitemid 29465985)
37. Nakamura, K., M. Niimi, K. Niimi, A. R. Holmes, J. E. Yates, A. Decottig-nies, B. C. Monk, A. Goffeau, and R. D. Cannon. 2001. Functional expression of Candida albicans drug efflux pump Cdrlp in a Saccharomyces cerevisiae strain deficient in membrane transporters. Antimicrob. Agents Chemother. 45:3366-3374. (Pubitemid 33107848)
38. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Ap-proved standard M27-A. National Committee for Clinical Laboratoiy Stan-dards, Wayne, PA.
39. Niimi, K., D. R. Harding, R. Parshot, A. King, D. J. Lun, A. Decottignies, M. Niimi, S. Lin, R. D. Cannon, A. Goffeau, and B. C. Monk. 2004. Chemosen-sitization of fluconazole resistance in Saccharomyces cerevisiae and patho-genic fungi by a D-octapeptide derivative. Antimicrob. Agents Chemother. 48:1256-1271. (Pubitemid 38405480)
40. Odds, F. C. 2003. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52:1. (Pubitemid 36850074)
41. Pfaller, M. A., and D. J. Diekema. 2002. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol. 40:3551-3557.
42. Prasad, R., N. A. Gaur, M. Gaur, and S. S. Komath. 2006. Efflux pumps in drug resistance of Candida. Infect. Disord. Drug Targets 6:69-83. (Pubitemid 43881017)
43. Prasad, R., P. De Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDRl, conferring multiple resistance to drugs and antifungals. Curr. Genet. 4:320-329.
44. Ramu, A., and N. Ramu. 1992. Reversal of multidrug resistance by phe-nothiazines and structurally related compounds. Cancer Chemother. Phar-macol. 30:165-173. (Pubitemid 24261283)
45. Reid, R. J. D., M. Lisby, and R. Rothstein. 2002. Cloning-free genome alterations in Saccharomyces cerevisiae using adaptamer-mediated FCR. Methods Enzymol. 350:258-277. (Pubitemid 34619496)
46. Sanglard, D., and J. Bille. 2002. Current understanding of the modes of action and resistance mechanisms to conventional and emerging antifungal agents for treatment of Candida infections, p. 349-387. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, DC.
47. Sanglard, D., F. Ischer, M. Monod, and J. BiIIe. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40:2300-2305. (Pubitemid 26328036)
48. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characteriza-tion of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416. (Pubitemid 27092176)
49. Sarkadi, B., L. Homolya, and Z. Hollo. August 2001. Assay and reagent kit for evaluation of multi-drug resistance in cells. U.S. patent 6,277,655.
50. Servos, J., E. Haase, and M. Brendel. 1993. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-iV-oxide and other chemicals, encodes a 169 kDa protein homologous to ATF-dependent per-meases. MbI. Gen. Genet. 236:214-218. (Pubitemid 23055558)
51. Shukla, S., P. Saini, Smriti, S. Jha, S. V. Ambudkar, and R. Prasad. 2003. Functional characterization of Candida albicans ABC transporter Cdrlp. Eukaryot. Cell 2:1361-1375. (Pubitemid 38047243)
52. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cere\>isiae. Genetics 122:19-27.
53. Souid, A. K., C. Gao, L. Wang, E. Milgrom, and W. C. Shen. 2006. ELMl is required for multidrug resistance in Saccharomyces cerevisiae. Genetics 173: 1919-1937. (Pubitemid 44285673)
54. Tanabe, K., E. Lamping, K. Adachi, Y. Takáno, K. Kawabata, Y. Shizuri, M. Niimi, and Y. Uehara. 2007. Inhibition of fungal ABC transporters by un-narmicin A and unnarmicin C. novel cyclic peptides from marine bacterium. Biochem. Biophys. Res. Commun. 364:990-995. (Pubitemid 350087898)
55. Torelli, R., B. Posteraro, S. Ferrari, M. La Sorda, G. Fadda, D. Sanglard, and M. Sanguinetti. 2008. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgfDÄY-dependent azole resistance of Candida glabrata. MoI. Microbiol. 68:186-201.
56. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sei. USA 76:4350-4354. (Pubitemid 9256559)
57. Weiss, J., S. M. Dormann, M. Martin-Facklam, C. J. Kerpen, N. Ketabi-Kiyanvash, and W. E. Haefeli. 2003. Inhibition of P-glycoprotein by newer antidepressants. J. Pharmacol. Exp. Ther. 305:197-204. (Pubitemid 36373851)
58. White, R. L., D. S. Burgess, M. Manduru, and J. A. Bosso. 1996. Comparison of three different in vitro methods of detecting synergy: time-kill, checker-board, and E test. Antimicrob. Agents Chemother. 40:1914-1918. (Pubitemid 26277815)
59. White, T. C, S. Holleman, F. Dy, L. F. Mireis, and D. A. Stevens. 2002. Resistance mechanisms in clinicai isolates of Candida albicans. Antimicrob. Agents Chemother. 6:1704-1713. (Pubitemid 34535186)
60. Wilson, R. B., D. Davis, B. M. Enloe, and A. P. Mitchell. 2000. A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast 16:65-70. (Pubitemid 30066097)
61. Yang, H. C, Y. Mikami, T. Imai, H. Taguchi, K. Nishimura, M. Miyaji, and M. L. Branchini. 2001. Extrusion of fluorescein diacetate by multidrug-resistant Candida. Mycoses 44:368-374. (Pubitemid 34015718)
62. Zhang, J. H., T. D. Y. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73. (Pubitemid 29278954)